Sensient Technologies (SXT) director defers fees into deferred stock units

Rhea-AI Filing Summary

Sensient Technologies Corp. director Form 4 shows a routine fee deferral into stock-based compensation. On 12/31/2025, the director elected to defer fees under the company’s Directors’ Deferred Compensation Plan, receiving 388.771 units of deferred stock that convert into common shares on a one-for-one basis.

After this transaction, the director beneficially owns 22,484.448 shares of common stock directly and 23,263.025 derivative securities classified as deferred stock. The filing explains that common shares from the deferred stock will be issued when the director’s board service ends, and current holdings also include restricted stock under the 2017 Stock Plan and shares held through a dividend reinvestment plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Carleone Joseph

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock	388.771	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Deferred Stock — 23,263.025 shares (Direct); Common Stock — 22,484.448 shares (Direct)

Footnotes (1)

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Deferred stock converts to common stock on a one-for-one basis. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carleone Joseph

(Last) (First) (Middle)

777 EAST WISCONSIN AVENUE

(Street)

MILWAUKEE WI 53202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								22,484.448(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock	(2)	12/31/2025		A(3)		388.771		(4)	(4)	Common Stock	388.771	$0	23,263.025	D

Explanation of Responses:

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

2. Deferred stock converts to common stock on a one-for-one basis.

3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.

4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

	/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Sensient Technologies (SXT) report on this Form 4?

The Form 4 reports that a Sensient Technologies Corp. director deferred board fees on 12/31/2025 into 388.771 units of deferred stock, which will later convert into common shares.

How many Sensient Technologies (SXT) deferred stock units did the director receive?

The director received 388.771 deferred stock units. Each unit converts into one share of Sensient Technologies common stock.

What is the director’s total beneficial ownership of Sensient Technologies (SXT) common stock after the transaction?

Following the reported transaction, the director beneficially owns 22,484.448 shares of Sensient Technologies common stock directly and 23,263.025 derivative securities classified as deferred stock.

When will the deferred stock for the Sensient Technologies (SXT) director be issued as common shares?

The filing states that shares of Sensient Technologies common stock underlying the deferred stock will be issued when the reporting person’s service as a director terminates.

What plan governs the deferred stock reported by the Sensient Technologies (SXT) director?

The deferred stock arises from the director’s deferral of fees under Sensient Technologies’ Directors’ Deferred Compensation Plan.

What other equity holdings are included in the Sensient Technologies (SXT) director’s reported ownership?

The reported common stock holdings include shares of restricted stock under the company’s 2017 Stock Plan, as amended and restated, as well as shares held in a dividend reinvestment plan.